HeartBeam has submitted a 510(k) application to the US Food and Drug Administration (FDA) for its 12-lead electrocardiogram ...

SANTA CLARA, Calif. - HeartBeam, Inc. (NASDAQ: BEAT), a $56.5 million market cap pioneer in medical technology currently trading at $2.12 per share, has announced the submission of a 510(k) ...

The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five clinical sites. The Company believes the study's findings support the clinical ...

After a long health journey with the Apple Watch, our tech writer spoke with medical experts about how to best implement the ...

Machine vision accelerates robotics precision across industries. Apple leads wearables with premium health tracking, while ...

Over the past 15 years, Bluetooth technology has become a staple of the in-car experience, making connectivity between driver and mobile device a reality. This wireless communication tool has ...

The FDA is elevating a recall from Philips related to one of its wearable outpatient heart monitors, used to help detect cases of hidden, transient arrhythmias that may only last minutes at a time.

The data was also presented at the 2024 CINC Conference in October. Kardia 12L performed comparably to the standard 12-lead ECG in detecting major morphology-related abnormalities. “AliveCor’s Kardia ...

Despite pricing that would compete with the Galaxy Watch 6 at the time (and later the Watch 7), OnePlus skipped out on crucial features such as cellular connectivity and an electrocardiogram (ECG).

Kardia 12L performed comparably to the standard 12-lead ECG in detecting major morphology-related abnormalities. "AliveCor's Kardia 12L ECG System was born from our vision to leverage AI and ...

The results indicated that Kardia 12L ECG System (with its reduced leadset) performed comparably to the standard 12-lead ECG in detecting major morphology-related abnormalities, including bundle ...